Total planned funding: $1,786,598,315
Allocations
Countries/Regions
South Africa | $301,155,968 |
Kenya | $285,563,621 |
Nigeria | $242,900,274 |
Tanzania | $172,520,561 |
Uganda | $144,541,702 |
Ethiopia | $134,713,288 |
Zambia | $127,610,396 |
Mozambique | $83,922,247 |
Rwanda | $63,559,742 |
Haiti | $55,184,401 |
Côte d'Ivoire | $50,486,893 |
Namibia | $35,884,687 |
Botswana | $28,048,832 |
Vietnam | $19,690,136 |
Zimbabwe | $12,472,250 |
Guyana | $9,436,951 |
Eswatini | $4,468,000 |
Malawi | $2,727,777 |
Cambodia | $2,570,272 |
Democratic Republic of the Congo | $2,405,547 |
India | $2,012,932 |
Lesotho | $1,365,000 |
Russia | $885,000 |
Dominican Republic | $747,882 |
Ghana | $650,000 |
China | $622,900 |
Caribbean Region | $286,056 |
Indonesia | $165,000 |
Organizational Types
Unknown | $783,694,891 |
Private Contractor | $371,341,411 |
NGO | $245,352,425 |
University | $158,246,210 |
Implementing Agency | $106,756,589 |
FBO | $73,922,900 |
Host Country Government Agency | $36,990,230 |
Own Agency | $3,467,163 |
Multi-lateral Agency | $3,334,048 |
Parastatal | $2,971,368 |
Other USG Agency | $521,080 |
Program Areas
Treatment | $1,786,598,315 |
Budget Codes
HTXS: Treatment: Adult Treatment | $1,038,589,925 |
HTXD: Treatment: ARV Drugs | $643,367,263 |
PDTX: Treatment: Pediatric Treatment | $104,641,127 |